Accendra Health
249 hedge funds and large institutions have $2.47B invested in Accendra Health in 2022 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 81 increasing their positions, 93 reducing their positions, and 45 closing their positions.
175% more call options, than puts
Call options by funds: $12.7M | Put options by funds: $4.63M
2.38% more ownership
Funds ownership: 100.5% → 102.88% (+2.4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less funds holding
Funds holding: 265 → 249 (-16)
13% less repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 93
20% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 45
27% less capital invested
Capital invested by funds: $3.39B → $2.47B (-$923M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$52.7M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$31.7M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$27.8M |
| 4 |
Morgan Stanley
New York
|
+$14.9M |
| 5 |
AIM
Artemis Investment Management
Edinburgh,
United Kingdom
|
+$13.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CVA
Ceredex Value Advisors
Orlando,
Florida
|
-$32.6M |
| 2 |
D.E. Shaw & Co
New York
|
-$27M |
| 3 |
Millennium Management
New York
|
-$13.6M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$12.1M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$10.6M |
ACH Hedge Fund Activity: Q2 2022 in Review
249 of the 5,961 institutional investors tracked by Wall St. Rank reported a position in Accendra Health (ACH) for Q2 2022, worth a combined $2.47B — down 27% from $3.39B a quarter earlier.
Sellers outnumbered buyers: 45 funds closed out of ACH and 36 opened new positions — a net loss of 9 holders — while 93 trimmed existing stakes and 81 added.
The largest buyer was Fidelity Investments, adding an estimated $52.7M. The largest seller was Ceredex Value Advisors, exiting entirely with an estimated $32.6M sold.
- 249 institutional investors held Accendra Health (ACH) as of Q2 2022, down from 265 in Q1 2022.
- Funds reported $2.47B of Accendra Health stock for Q2 2022, down 27% quarter-over-quarter.
- 36 funds opened new Accendra Health positions in Q2 2022 and 45 closed out, a net change of -9 holders.
- The largest Accendra Health buyer in Q2 2022 was Fidelity Investments, an estimated $52.7M added.
- The largest Accendra Health seller in Q2 2022 was Ceredex Value Advisors, an estimated $32.6M sold.
Based on aggregated 13F filings for Q2 2022.